Fidelity International
TRML

Fidelity International’s Tourmaline Bio TRML Stock Holding History

Fidelity International’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,027,690
Closed -$49.2M – 1082
2025
Q3 		$49.2M Buy
+1,027,690
New +$28.5M 0.04% 348

Fidelity International's TRML Position: Q4 2025 in Review

Fidelity International sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 1,027,690 shares — an estimated $49.2M sold.

Fidelity International first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $49.2M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • Fidelity International reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • Fidelity International sold 1,027,690 Tourmaline Bio shares in Q4 2025, an estimated $49.2M.
  • Fidelity International first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
  • Fidelity International's Tourmaline Bio position peaked at $49.2M in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Fidelity International's 13F filing for Q4 2025, filed 17 Feb 2026.